OLA
CVS icon

Oliver Luxxe Assets’s CVS Health CVS Stock Holding History

Oliver Luxxe Assets’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Buy
134,539
+28,052
+26% +$2.5M 2.05% 3
2026
Q1 		$7.65M Buy
106,487
+3,041
+3% +$234K 1.15% 19
2025
Q4 		$8.21M Buy
103,446
+14,447
+16% +$1.14M 1.25% 22
2025
Q3 		$6.71M Buy
+88,999
New +$6.1M 1.06% 30
2021
Q1 		– Sell
-38,180
Closed -$2.9M – 180
2020
Q4 		$2.9M Sell
38,180
-9,725
-20% -$633K 0.91% 39
2020
Q3 		$2.8M Buy
47,905
+2,620
+6% +$163K 1.04% 34
2020
Q2 		$2.94M Buy
45,285
+945
+2% +$59.5K 1.55% 22
2020
Q1 		$2.63M Buy
44,340
+15,615
+54% +$1.04M 1.65% 21
2019
Q4 		$2.13M Buy
+28,725
New +$2.02M 1.11% 39
2019
Q1 		– Sell
-49,214
Closed -$3.23M – 116
2018
Q4 		$3.23M Buy
49,214
+78
+0.2% +$5.82K 2.17% 9
2018
Q3 		$3.87M Buy
+49,136
New +$3.51M 2.19% 8
2016
Q1 		– Sell
-3,437
Closed -$334K – 80
2015
Q4 		$334K Buy
+3,437
New +$337K 0.3% 84

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Oliver Luxxe Assets's CVS Position: Q2 2026 in Review

Oliver Luxxe Assets increased its CVS Health (CVS) stake by 26% in Q2 2026, buying an estimated $2.5M and bringing the position to 134,539 shares worth $13.9M. The position accounts for 2.05% of the portfolio, ranked #3.

Oliver Luxxe Assets first reported a position in CVS in Q4 2015 and has held it in 12 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Oliver Luxxe Assets held 134,539 shares of CVS Health worth $13.9M as of Q2 2026.
  • Oliver Luxxe Assets bought 28,052 CVS Health shares in Q2 2026, an estimated $2.5M.
  • CVS Health made up 2.05% of Oliver Luxxe Assets's portfolio in Q2 2026, its #3 holding.
  • Oliver Luxxe Assets first reported a position in CVS Health in Q4 2015 and has held it in 12 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.